Evidence map›Paper›PMID 35719798›Full record

ArticleCureus2022

Diabetic Patients' Perspective About New Technologies Used in Managing Diabetes Mellitus in Saudi Arabia: A Cross-Sectional Study.

Omar M Al-Nozha, Esraa K Alshareef, Afnan F Aljawi, Enas T Alhabib, Raghad S AlMahweeti, Sarah A Aljuhani, Sawsan A Alamri, Ohoud S Alahmadi

Abstract read
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Real-World Effectiveness of My Dose Coach™-Assisted Basal Insulin Titration in People with Type 2 Diabetes in Saudi Arabia and Kuwait.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Omar M Al-NozhaInternal Medicine, Taibah University, Madina, SAU.
Esraa K AlshareefMedicine and Surgery, Taibah University, Madina, SAU.
Afnan F AljawiMedicine and Surgery, Taibah University, Medina, SAU.
Enas T AlhabibMedicine and Surgery, Taibah University, Madina, SAU.
Raghad S AlMahweetiMedicine and Surgery, Taibah University, Madina, SAU.
Sarah A AljuhaniMedicine and Surgery, Taibah University, Madina, SAU.
Sawsan A AlamriMedicine and Surgery, Taibah University, Madina, SAU.
Ohoud S AlahmadiMedicine and Surgery, Taibah University, Madina, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes technologies are hardware, devices, and software that are used by people with diabetes to manage their condition, from lifestyle interventions to the monitoring of blood glucose levels. The development of these technologies is advancing, but their use in Saudi Arabia is under-researched.

objectivesTo appraise the awareness of using new technological options in managing patients with diabetes and to assess the patients' satisfaction while using them.

methodThis was an e-questionnaire-based cross-sectional study. The targeted population of the study was patients with diabetes in Saudi Arabia. A total of 452 respondents participated in a survey in the period between 2020 and 2021. The collected data were analyzed using descriptive statistical methods and Chi-squared tests.

resultsSome 69% of participants were aware of the new technologies used in managing diabetes. There were discrepancies between the awareness and the use of new technologies. Several causes of non-use were identified; the main cause was high cost, as reported by more than half of non-users (53.2%). Other causes included non-availability and difficulty of use. Mobile health applications had the highest use rate (13.5%) among new technologies; patients reported using them mostly for blood glucose monitoring, physical activity, and nutritional programs. Patients' satisfaction was higher for modern technologies than for conventional methods.

conclusionThe results indicate that awareness of the new technologies used in managing diabetes was higher than their use. Moreover, the use of modern technologies improved the satisfaction of patients.

Indexed as

awarenessdiabetes mellitusmanagementnew technologiessatisfaction

Identifiers

PMID35719798
PMCPMC9198967

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.